Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 1, 2019
View Archived Issues
MYRF gene mutations linked to the development of nanophthalmos
Read More
VNLG-152R shows promising antitumor and antimetastatic activity in models of TNBC
Read More
Mutations in ADAMTSL1 are responsible for the pathogenesis of mandibular prognathism
Read More
Antiviral etravirine increases frataxin levels: a potential therapy for Friedreich's ataxia
Read More
NB-360 improves memory deficit in mice
Read More
Rhythm Pharmaceuticals provides update on setmelanotide development program
Read More
Potent new glucocorticoid reverses severe steroid-resistant asthma
Read More
Proteo initiates clinical development of subcutaneous Elafin
Read More
MR-35602, a novel triple-activity compound with promising activity in model of AD
Read More
Merck & Co. presents novel AD-specific tau monoclonal antibody, MAFT-0617
Read More
Alpelisib plus olaparib demonstrates promising activity and safety in phase I study
Read More
XenoTherapeutics initiates phase I study of Xeno-Skin
Read More
Targeting hair loss outside the follicle
Read More
No pain, emotional gain due to newly identified mutation
Read More
BioThera Solutions recruiting participants in phase I study of BAT-8003
Read More
Immunic patents IFN-gamma and IL-17 production inhibitors
Read More
GlaxoSmithKline divulges new MYC, p300 and CREBBP inhibitors
Read More
Hutchison MediPharma identifies IDH inhibitors
Read More
Chiesi Farmaceutici presents ROCK1 and ROCK2 inhibitors
Read More
FDA approves Mavenclad for relapsing-remitting and active secondary progressive MS
Read More
Cancer vaccine iNeo-Vac-P01 safe and beneficial in patients with solid tumors
Read More
BeiGene discloses PI3Kdelta inhibitors
Read More
Auris announces randomization of first dose cohort in phase Ib study of AM-201
Read More
Actinium advances antibody radiation conjugate research program with Astellas
Read More
FDA approves Duaklir for maintenance treatment of COPD
Read More
Poxel initiates phase IIa NASH program with PXL-770
Read More
Phio and Glycostem explore synergies of technologies for cancer immunotherapy
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe